Ichnos Sciences signs licensing pact with Astria Therapeutics for OX40 antagonist monoclonal antibody portfolio Read more
USFDA accepts Eisai’s sBLA and grants priority review for approval of LEQEMBITM Alzheimer’s treatment Read more